Terms: = Uterine cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
201 results:
1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the causal association between rheumatoid arthritis and the risk of cervical cancer: a two-sample Mendelian randomization study.
Xu M; Chen H; Tan T; Xie K; Xie H; Li Q
Arthritis Res Ther; 2024 Jan; 26(1):35. PubMed ID: 38263277
[TBL] [Abstract] [Full Text] [Related]
3. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
[No Abstract] [Full Text] [Related]
4. HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
Wang P; Yang B; Huang H; Liang P; Long B; Chen L; Yang L; Tang L; Huang L; Liang H
AIDS Res Ther; 2023 Nov; 20(1):82. PubMed ID: 37981694
[TBL] [Abstract] [Full Text] [Related]
5. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National cancer Registration Service in England.
Goulden S; Heffernan K; Sen Nikitas F; Shukla U; Knott C; Hunger M; Pahwa A; Schade R
Int J Gynecol Cancer; 2023 Nov; 33(11):1715-1723. PubMed ID: 37620100
[TBL] [Abstract] [Full Text] [Related]
7. [Safety and feasibility of right colectomy via a transvaginal approach: early experience from a single center].
Xiao Y; Sun Z; Sun R; Hou WY; Xu L; Lu JY
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jun; 26(6):588-594. PubMed ID: 37583013
[No Abstract] [Full Text] [Related]
8. Analysis of E-cadherin (cdh1) Gene Polymorphism and Its Association with Cervical cancer Risk in Bangladeshi Women.
Rahman MA; Hasan MM; Hossain A; Alam KM; Sultana R; Mazid MA; Rahman MM
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2361-2368. PubMed ID: 37505767
[TBL] [Abstract] [Full Text] [Related]
9. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical cancer Specimens.
Haqshenas G; Molano M; Phillips S; Balgovind P; Garland SM; Hawkes D; Brotherton JM; Machalek DA; Murray G
Arch Pathol Lab Med; 2024 Mar; 148(3):353-358. PubMed ID: 37226838
[TBL] [Abstract] [Full Text] [Related]
11. Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma.
Kuang T; Li L; Chen Y; Wang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):15-23. PubMed ID: 36935173
[TBL] [Abstract] [Full Text] [Related]
12. Associations of Dietary Intakes with Gynecological cancers: Findings from a Cross-Sectional Study.
Zhu G; Li Z; Tang L; Shen M; Zhou Z; Wei Y; Zhao Y; Bai S; Song L
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501056
[TBL] [Abstract] [Full Text] [Related]
13. Three-dimensional ultrasound VOCAL combined with contrast-enhanced ultrasound: an alternative to contrast-enhanced magnetic resonance imaging for evaluating ablation of benign uterine lesions.
Zhang J; Lyu G; Qiu J; Qiu S; Li Z; Lin M; Xiao X; Tang L; He J; Li X; Li S
Int J Hyperthermia; 2022; 39(1):1360-1370. PubMed ID: 36266251
[TBL] [Abstract] [Full Text] [Related]
14. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH; Wu T; Hu YM; Wei LH; Li MQ; Huang WJ; Chen W; Huang SJ; Pan QJ; Zhang X; Hong Y; Zhao C; Li Q; Chu K; Jiang YF; Li MZ; Tang J; Li CH; Guo DP; Ke LD; Wu X; Yao XM; Nie JH; Lin BZ; Zhao YQ; Guo M; Zhao J; Zheng FZ; Xu XQ; Su YY; Zhang QF; Sun G; Zhu FC; Li SW; Li YM; Pan HR; Zhang J; Qiao YL; Xia NS
Lancet Infect Dis; 2022 Dec; 22(12):1756-1768. PubMed ID: 36037823
[TBL] [Abstract] [Full Text] [Related]
16. Previously treated recurrent or advanced endometrial cancer in England: A real-world observational analysis.
Heffernan K; Nikitas FS; Shukla U; Camejo HS; Knott C
Gynecol Oncol; 2022 Aug; 166(2):317-325. PubMed ID: 35752507
[TBL] [Abstract] [Full Text] [Related]
17. The anaphase-promoting complex/cyclosome co-activator, cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesis.
Jaiswal N; Nandi D; Cheema PS; Nag A
Carcinogenesis; 2022 Nov; 43(10):988-1001. PubMed ID: 35738876
[TBL] [Abstract] [Full Text] [Related]
18. Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.
Kudo R; Sekine M; Yamaguchi M; Hara M; Hanley SJB; Kurosawa M; Adachi S; Ueda Y; Miyagi E; Ikeda S; Yagi A; Enomoto T
Cancer Sci; 2022 Sep; 113(9):3211-3220. PubMed ID: 35730321
[TBL] [Abstract] [Full Text] [Related]
19. Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
Xu Y; Kong W; Cao M; Wang J; Wang Z; Zheng L; Wu X; Cheng R; He W; Yang B; Dong B; Pan J; Chen Y; Huang J; Jiang C; Zhai W; Li F; Chen R; Zhou X; Wu G; Geng X; Chen J; An H; Yuan Y; Xu T; Chen D; Lin D; Xu L; Huang K; Peng L; Yu Y; Tai S; Qi H; Luo K; Kang X; Wang H; Huang Y; Zhang J; Xue W
Eur Urol; 2023 Feb; 83(2):163-172. PubMed ID: 35715365
[TBL] [Abstract] [Full Text] [Related]
20. FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity.
Sahoo SS; Ramanand SG; Gao Y; Abbas A; Kumar A; Cuevas IC; Li HD; Aguilar M; Xing C; Mani RS; Castrillon DH
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35703180
[TBL] [Abstract] [Full Text] [Related]
[Next]
